VRNA Verona Pharma plc Forecast, Technical & Fundamental Analysis

a r&d company for the treatment of allergic rhinitis and other chronic respiratory diseases

Industry Biotechnology

Get AI intraday signals

VRNA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For VRNA
(Try 14 days for Free)

View a ticker or compare two or three

Compare

VRNA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For VRNA
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

VRNA is expected to report earnings to rise 2.86% to -7 cents per share on February 27

Verona Pharma plc VRNA Stock Earnings Reports

Q4'24

Est.

$-0.07

Q3'24

Est.

$-0.07

Q2'24

Missed

by $0.06

Q1'24

Missed

by $0.01

Q4'23

Beat

by $0.01

The last earnings report on November 04 showed earnings per share of -7 cents, meeting the estimate of -7 cents. With 843.68K shares outstanding, the current market capitalization sits at 3.41B.

A.I. Advisor

published General Information

General Information

a r&d company for the treatment of allergic rhinitis and other chronic respiratory diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

3 More London Riverside

Phone

+44 2032834200

Employees

Web

https://www.veronapharma.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
TSLA	463.02	26.79	+6.14%
Tesla
GME	29.44	1.45	+5.18%
GameStop Corp
BTC.X	106029.720000	1731.023400	+1.66%
Bitcoin cryptocurrency
AAPL	251.04	2.91	+1.17%
Apple
SPY	606.79	2.58	+0.43%
SPDR® S&P 500® ETF Trust

VRNA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VRNA has been loosely correlated with RNA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if VRNA jumps, then RNA could also see price increases.

Ticker / NAME	Correlation To VRNA	1D Price Change %
VRNA	100%	+3.04%
RNA - VRNA	34% Loosely correlated	+2.77%
AKBA - VRNA	34% Loosely correlated	-0.54%
PLRX - VRNA	33% Loosely correlated	+3.16%
TRDA - VRNA	33% Poorly correlated	+1.98%
ALT - VRNA	32% Poorly correlated	-0.33%
More